IL6 and myocardial infarction: In the present study, we showed that the expression levels of inflammatory cytokines including Mcp1 and Il6 were dramatically suppressed by SR9009 treatment in the LV during the acute phase of MI, and that of Mmp9 was also suppressed by SR9009 treatment.